Insulin aspart, recombinant Subcutaneous and Prucalopride Succinate
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Prucalopride Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: prucalopride
Brand name: Motegrity
Synonyms: Prucalopride
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Prudoxin
- Insulin aspart, recombinant Subcutaneous-Prudoxin Topical
- Insulin aspart, recombinant Subcutaneous-Pryflex
- Insulin aspart, recombinant Subcutaneous-Pseudodine C
- Insulin aspart, recombinant Subcutaneous-Pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Pseudoephedrine and Codeine
- Prucalopride Succinate-Insulin degludec
- Prucalopride Succinate-Insulin Degludec (U-100) Prefilled Pens
- Prucalopride Succinate-Insulin Degludec (U-100) Vials
- Prucalopride Succinate-Insulin Degludec (U-200) Prefilled Pens
- Prucalopride Succinate-Insulin degludec and liraglutide
- Prucalopride Succinate-Insulin degludec and liraglutide Subcutaneous